Skip to main content

Advertisement

SpringerLink
Log in

Osteoporosis after solid organ and bone marrow transplantation

  • Review
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Organ transplantation has become increasingly common as a therapy for end-stage renal, liver, cardiac and pulmonary disease. The population of patients who have survived organ transplantation has grown dramatically over the last 2 decades. Although organ transplant recipients now benefit from greatly improved survival, long-term complications of organ transplantation, such as osteoporosis, adversely affect quality of life and must be addressed. In the early post-transplantation period, the effects of high dose glucocorticoids, combined with other immunosuppressive drugs such as cycosporine A and tacrolimus, cause rapid bone loss particularly at the spine and proximal femur. In this setting, fracture incidence rates as high as 25–65% have been reported. Treatment and prevention strategies must target this early post-transplant period, as well as the patient awaiting transplantation and the long-term transplant recipient. This review will discuss the clinical features of transplantation osteoporosis, the pathophysiology of post-transplantation bone loss and prevention and therapy of this unique bone disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1a,b

Similar content being viewed by others

References

  1. Goodman WG, Coburn JW, Slatopolsky E et al. (1999) Renal osteodystrophy in adults and children. In: Favus MJ, Christakos S (eds) Primer on the metabolic bone diseases and disorders of mineral metabolism, 4th edn. Lippincott-Raven, Philadelphia, pp 347–63

  2. Elder G (2002) Pathophysiology and recent advances in the management of renal osteodystrophy. Osteoporos Int 17:2094–2105

    CAS  Google Scholar 

  3. Hruska KA, Teitelbaum SL (1995) Renal osteodystrophy. N Engl J Med 333:166–174

    CAS  PubMed  Google Scholar 

  4. Stein M, Packham D, Ebeling P et al. (1996) Prevalence and risks factors for osteopoenia in dialysis patients. Am J Kidney Dis 28:515–522

    CAS  PubMed  Google Scholar 

  5. Taal MW, Masud T, Green D et al. (1999) Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant 14:1922–1928

    Article  CAS  PubMed  Google Scholar 

  6. Lechleitner P, Krimbacher E, Genser N et al. (1994) Bone mineral densitometry in dialyzed patients: quantitative computed tomography versus dual photon absorptiometry. Bone 15:387–391

    CAS  PubMed  Google Scholar 

  7. Atsumi K, Kushida K, Yamazaki K et al. (1999) Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33:287–293

    CAS  PubMed  Google Scholar 

  8. Gupta A, Kallenbach LR, Divine GW (1997) Increased risk of hip fracture in US Medicare end-stage renal disease patients. J Bone Miner Res 12:S274

    Google Scholar 

  9. Stehman-Breen CO, Sherrard DJ, Alem AM et al. (2000) Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 58:2200–2205

    Article  CAS  PubMed  Google Scholar 

  10. Ball AM, Gillen DL, Sherrard D et al. (2002) Risk of hip fracture among dialysis and renal transplant recipients. JAMA 288:3014–3018

    Article  PubMed  Google Scholar 

  11. Lee AH, Mull RL, Keenan GF et al. (1994) Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 96:35–41

    CAS  PubMed  Google Scholar 

  12. Muchmore JS, Cooper DKC, Ye Y et al. (1991) Loss of vertebral bone density in heart transplant patients. Transplant Proc 23:1184–1185

    CAS  PubMed  Google Scholar 

  13. Shane E, Mancini D, Aaronson K et al. (1997) Bone mass, vitamin D deficiency and hyperparathyroidism in congestive heart failure. Am J Med 103:197–207

    Article  CAS  PubMed  Google Scholar 

  14. Maddrey WC (1990) Bone disease in patients with primary biliary cirrhosis. Prog. Liver Dis 9:537–554

    CAS  Google Scholar 

  15. Hodgson SF, Dickson ER, Wahner HW et al. (1980) Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Int Med 103:855–860

    Google Scholar 

  16. Janes CH, Dickson ER, Okazaki R et al. (1995) Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 95:2581–2586

    CAS  PubMed  Google Scholar 

  17. Friday KE, Howard GA (1991) Ethanol inhibits human bone cell proliferation and function in vitro. Metabolism 40:562–565

    CAS  PubMed  Google Scholar 

  18. Bikle DD (1993) Alcohol-induced bone disease. World Rev Nutr Diet 73:53–79

    CAS  PubMed  Google Scholar 

  19. Peris P, Guanabens N, Pares A et al. (1995) Vertebral fractures and osteopenia in chronic alcoholic patients. Calcif Tissue Int 57:111–114

    CAS  PubMed  Google Scholar 

  20. Trautwein C, Possienke M, Schlitt H et al. (2000) Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol 95:2343–2451

    Article  CAS  PubMed  Google Scholar 

  21. Diamond T, Stiel D, Posen S (1989) Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Int Med 110:430–436

    Google Scholar 

  22. Stellon AJ, Davies A, Compston J et al. (1985) Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy. Gastroenterology 89:1078–1083

    CAS  PubMed  Google Scholar 

  23. Olsson R, Johansson C, Lindstedt G et al. (1994) Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol 29:753–756

    CAS  PubMed  Google Scholar 

  24. Crosbie OM, Freaney R, McKenna MJ et al. (1999) Bone density, vitamin D status, and disordered bone remodeling in end-stage chronic liver disease. Calcif Tissue Int 64:295–300

    Article  CAS  PubMed  Google Scholar 

  25. Monegal A, Navasa M, Guanabens N et al. (1997) Osteoporosis and bone mineral metabolism in cirrhotic patients referred for liver transplantation. Calcif Tissue Int 60:148–154

    Article  CAS  PubMed  Google Scholar 

  26. Floreani A, Mega A, Tizian L et al. (2001) Bone metabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study. Osteoporos Int 12:749–754

    Article  CAS  PubMed  Google Scholar 

  27. Ninkovic M, Love SA, Tom B et al. (2001) High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int 69:321–326

    CAS  PubMed  Google Scholar 

  28. Monegal A, Navasa M, Guanabens N et al. 2001 Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 12:484–492

    Google Scholar 

  29. Ott SM, Aitken ML (1998) Osteoporosis in patients with cystic fibrosis. Clin Chest Med 19:555–567

    CAS  PubMed  Google Scholar 

  30. Aris R, Neuringer I, Weiner M et al. (1996) Severe osteoporosis before and after lung transplantation. Chest 109:1176–1183

    CAS  PubMed  Google Scholar 

  31. Donovan DS Jr, Papadopoulos A, Staron RB et al. (1998) Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 157:1892–1899

    Google Scholar 

  32. Shane E, Silverberg SJ, Donovan D et al. (1996) Osteoporosis in lung transplantation candidates with end stage pulmonary disease. Am J Med 101:262–269

    Article  CAS  PubMed  Google Scholar 

  33. Trombetti A, Gerbase MW, Spiliopoulos A et al. (2000) Bone mineral density in lung-transplant recipients before and after graft: prevention of lumbar spine post-transplantation-accelerated bone loss by pamidronate. J Heart Lung Transplant 19:736–743

    Article  CAS  PubMed  Google Scholar 

  34. Ferrari SL, Nicod LP, Hamacher J et al. (1996) Osteoporosis in patients undergoing lung transplantation. Eur Respir J 9:2378–2382

    Google Scholar 

  35. Lien D, Jackson K, Monkhouse P et al. (2001) Intervention prevents progression of osteoporosis in patients awaiting lung transplantation. J Heart Lung Transplant 20:225

    Article  Google Scholar 

  36. Tschopp O, Boehler A, Speich R et al. (2002) Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease. Am J Transplant 2:167–172

    Article  PubMed  Google Scholar 

  37. Aris RM, Renner JB, Winders AD et al. (1998) Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Int Med 128:186–193

    CAS  Google Scholar 

  38. Elkin SL, Fairney A, Burnett S et al. (2001) Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 12:366–372

    Article  PubMed  Google Scholar 

  39. Haworth CS, Selby PL, Webb AK et al. (1999) Low bone mineral density in adults with cystic fibrosis. Thorax 54:961–967

    CAS  PubMed  Google Scholar 

  40. Elkin SL, Vedi S, Bord S et al. (2002) Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis. Am J Respir Crit Care Med 166:1470–1474

    Google Scholar 

  41. Schulte C, Beelen D, Schaefer U et al. (2000) Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospectiv estudy. Osteoporos Int 11:344–353

    Article  CAS  PubMed  Google Scholar 

  42. Cooper MS (2001) Glucocorticoid-induced osteoporosis. Curr Opin Endocrinol Diabet 8:140–145

    Article  CAS  Google Scholar 

  43. Van Staa TP, Leufkens HG, Abenhaim L et al. (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993–1000

    PubMed  Google Scholar 

  44. Lane NE, Lukert B (1998) The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin N Am 27:465–483

    CAS  Google Scholar 

  45. Weinstein R, Jilka R, Parfitt M et al. (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274–282

    CAS  PubMed  Google Scholar 

  46. Dempster DW (1989) Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 4:137–141

    CAS  PubMed  Google Scholar 

  47. Kahan BD (1989) Cyclosporine. N Engl J Med 321:1725–1738

    CAS  PubMed  Google Scholar 

  48. Suthanthiran M, Strom TB (1994) Renal transplantation. N Engl J Med 331:365–376

    Google Scholar 

  49. Epstein S (1996) Post-transplantation bone disease: the role of immunosuppressive agents on the skeleton. J Bone Miner Res 11:1–7

    CAS  PubMed  Google Scholar 

  50. Cvetkovic M, Mann GN, Romero DF et al. (1994) The deleterious effects of long term cyclosporin A, cyclosporin G and FK506 on bone mineral metabolism in vivo. Transplantation 57:1231–1237

    CAS  PubMed  Google Scholar 

  51. Orcel P, Denne MA, de Vernejoul MC (1991) Cyclosporin-A in vitro decreases bone resorption, osteoclast formation, and the fusion of cells of the monocyte-macrophage lineage. Endocrinology 128:1638–1646

    CAS  PubMed  Google Scholar 

  52. Schlosberg M, Movsowitz C, Epstein S et al. (1989) The effects of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology 124:2179–2184

    CAS  PubMed  Google Scholar 

  53. Movsowitz C, Epstein S, Fallon M et al. (1988) Cyclosporin A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 123:2571–2577

    CAS  PubMed  Google Scholar 

  54. Movsowitz C, Epstein S, Ismail F et al. (1989) Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption. J Bone Miner Res 4:393–398

    CAS  PubMed  Google Scholar 

  55. Bowman AR, Sass DA, Dissanayake IR et al. (1997) The role of testosterone in cyclosporine-induced osteopenia. J Bone Miner Res 12:607–615

    CAS  PubMed  Google Scholar 

  56. Epstein S, Dissanayake A, Goodman GR et al. (2001) Effect of the interaction of parathyroid hormone and cyclosporine A on bone mineral metabolism in the rat. Calcif Tissue Int 68:240–247

    CAS  PubMed  Google Scholar 

  57. Joffe I, Katz I, Jacobs T et al. (1992) 17 Beta estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin A. Endocrinology 130:1578–1586

    CAS  PubMed  Google Scholar 

  58. Bowman A, Sass D, Marshall I et al. (1995) Raloxifene analog (Ly 117018-HCL) ameliorates cyclosporin A induced osteopenia. J Bone Miner Res 10:350

    Google Scholar 

  59. Stein B, Takizawa M, Katz I et al. (1991) Salmon calcitonin prevents cyclosporin A induced high turnover bone loss. Endocrinology 129:92–98

    CAS  PubMed  Google Scholar 

  60. Sass DA, Bowman AR, Marshall I et al. (1997) Alendronate prevents cyclosporin-induced osteopenia in the rat. Bone 21:65–70

    Article  CAS  PubMed  Google Scholar 

  61. Awumey E, Moonga B, Sodam B et al. (1999) Molecular and functional evidence for calcineurin alpha and beta isoforms in the osteoclasts. Novel insights into the mode of action of cyclosporine A. Biochem Biophys Res Commun 254:148–252

    Article  Google Scholar 

  62. Buchinsky F, Ma Y, Mann G et al. (1996) T lymphocytes play a critical role in the development of cyclosporine induced osteopenia. Endocrinology 59:2278–2285

    Google Scholar 

  63. Ponticelli C, Aroldi A (2001) Osteoporosis after organ transplantation. Lancet 357:1623

    Article  CAS  Google Scholar 

  64. Grotz W, Mundinger A, Gugel B et al. (1994) Missing impact of cyclosporine on osteoporosis in renal transplant recipients. Transplant Proc 26:2652–2653

    CAS  PubMed  Google Scholar 

  65. McIntyre HD, Menzies B, Rigby R et al. (1995) Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens. Clin Transplant 9:20–24

    CAS  PubMed  Google Scholar 

  66. Inoue T, Kawamura I, Matsuo M et al. (2000) Lesser reduction in bone mineral density by the immunosuppresant, FK506, compared with cyclosporine in rats. Transplantation 70:774–779

    CAS  PubMed  Google Scholar 

  67. Stempfle HU, Werner C, Echtler S et al. (1998) Rapid trabecular bone loss after cardiac transplantation using FK506 (tacrolimus)-based immunosuppression. Transplant Proc 30:1132–1133

    CAS  PubMed  Google Scholar 

  68. Park KM, Hay JE, Lee SG et al. (1996) Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine. Transplant Proc 28:1738–1740

    CAS  PubMed  Google Scholar 

  69. Goffin E, Devogelaer JP, Depresseux G et al. (2001) Osteoporosis after organ transplantation. Lancet 357:1623

    Article  CAS  Google Scholar 

  70. Monegal A, Navasa M, Guanabens N et al. (2001) Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. Calcif Tissue Int 68:83–86

    CAS  PubMed  Google Scholar 

  71. Bryer HP, Isserow JA, Armstrong EC et al. (1995) Azathioprine alone is bone sparing and does not alter cyclosporine A induced osteopenia in the rat. J Bone Miner Res 10:132–138

    CAS  PubMed  Google Scholar 

  72. Dissanayake IR, Goodman GR, Bowman AR et al. (1998) Mycophenolate mofetil; a promising new immunosuppressant that does not cause bone loss in the rat. Transplantation 65:275–278

    CAS  PubMed  Google Scholar 

  73. Romero D, Buchinsky F, Rucinski B et al. (1995) Rapamycin: a bone sparing immunosuppressant? J Bone Miner Res 10:1556–1565

    Google Scholar 

  74. Julian BA, Laskow DA, Dubovsky J et al. (1991) Rapid loss of vertebral bone density after renal transplantation. N Engl J Med 325:544–550

    CAS  PubMed  Google Scholar 

  75. Grotz W, Nagel C, Poeschel D et al. (2001) Effect of ibandronate on bone loss and renal function after kidney transplantation. J Am Soc Nephrol 12:1530–1537

    CAS  PubMed  Google Scholar 

  76. Cayco AV, Wysolmerski J, Simpson C et al. (2000) Posttransplant bone disease: evidence for a high bone resorption state. Transplantation 70:1722–1728

    CAS  PubMed  Google Scholar 

  77. Carlini RG, Rojas E, Weisinger JR et al. (2000) Bone disease in patients with long-term renal transplantation and normal renal function. Am J Kidney Dis 36:160–166

    CAS  PubMed  Google Scholar 

  78. Monier-Faugere M, Mawad H, Qi Q et al. (2000) High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 11:1093–1099

    CAS  PubMed  Google Scholar 

  79. Cueto-Manzano A, Konel S, Hutchinson AJ et al. (1999) Bone loss in long term renal transplantation. Histopathology and densitometry analysis. Kidney Int 55:2021–2029

    Article  CAS  PubMed  Google Scholar 

  80. Bagni B, Gilli P, Cavallini A et al. (1994) Continuing loss of vertebral mineral density in renal transplant recipients. Eur J Nucl Med 21:108–112

    CAS  PubMed  Google Scholar 

  81. Pichette V, Bonnardeaux A, Prudhomme L et al. (1996) Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study. Am J Kidney Dis 28:105–114

    CAS  PubMed  Google Scholar 

  82. Boot AM, Nauta J, Hokken-Koelega ACS et al. (1995) Renal transplantation and osteoporosis. Arch Dis Child 72:502–506

    CAS  PubMed  Google Scholar 

  83. Heaf J, Tvedegaard E, Kanstrup IL et al. (2000) Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 14:457–463

    Article  CAS  PubMed  Google Scholar 

  84. Durieux S, Mercadal L, Orcel P et al. (2002) Bone mineral density and fracture prevalence in long-term kidney graft recipients. Transplantation 74:496–500

    CAS  PubMed  Google Scholar 

  85. Ugur A, Guvener N, Isiklar I et al. (2001) Osteoporosis after renal transplantation: single center experience. Transplantation 71:645–649

    CAS  PubMed  Google Scholar 

  86. Renau A, Yoldi B, Farrerons J et al. (2002) Bone mass and mineral metabolism in kidney transplant patients. Transplant Proc 34:407

    Article  CAS  PubMed  Google Scholar 

  87. Wolpaw T, Deal CL, Fleming-Brooks S et al. (1994) Factors influencing vertebral bone density after renal transplantation. Transplantation 58:1186–1189

    CAS  PubMed  Google Scholar 

  88. Torregrosa JV, Campistol JM, Montesinos M et al. (1995) Factors involved in the loss of bone mineral density after renal transplantation. Transplant Proc 27:2224–2225

    CAS  PubMed  Google Scholar 

  89. Yun YS, Kim BJ, Hong TW et al. (1996) Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after transplantation. Transplant Proc 28:1561–1564

    CAS  PubMed  Google Scholar 

  90. Horber FF, Casez JP, Steiger U et al. (1994) Changes in bone mass early after kidney transplantation. J Bone Miner Res 9:1–9

    CAS  PubMed  Google Scholar 

  91. Almond MK, Kwan JTC, Evans K et al. (1994) Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 66:52–57

    CAS  PubMed  Google Scholar 

  92. Moreno A, Torregrosa JV, Pons F et al. (1999) Bone mineral density after renal transplantation: long-term follow-up. Transplant Proc 31:2322–2323

    Article  CAS  PubMed  Google Scholar 

  93. Masse M, Girardin C, Ouimet D et al. (2001) Initial bone loss in kidney transplant recipients: a prospective study. Transplant Proc 33:1211

    Article  CAS  PubMed  Google Scholar 

  94. Cruz DN, Wysolmerski JJ, Brickel HM et al. (2001) Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study. Transplantation 72:83–88

    CAS  PubMed  Google Scholar 

  95. Farmer CKT, Hampson G, Vaja S et al. (2002) Late low dose steroid withdrawal in renal transplant recipients increases bone formation and bone mineral density without altering renal function: a randomized controlled trial. J Bone Miner Res 17:S158

    Google Scholar 

  96. Shane E, Epstein S (2001) Transplantation osteoporosis. Transplant Rev 15:11–32

    Google Scholar 

  97. Ramsey-Goldman R, Dunn JE, Dunlop DD et al. (1999) Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14:456–463

    CAS  PubMed  Google Scholar 

  98. Nisbeth U, Lindh E, Ljunghall S et al. (1999) Increased fracture rate in diabetes mellitus and females after renal transplantation. Transplantation 67:1218–1222

    CAS  PubMed  Google Scholar 

  99. O'Shaughnessy EA, Dahl DC, Smith CL et al. (2002) Risk factors for fractures in kidney transplantation. Transplantation 74:362–366

    PubMed  Google Scholar 

  100. Nisbeth U, Lindh E, Ljunghall S et al. (1994) Fracture frequency after kidney transplantation. Transplant Proc 26:1764

    CAS  PubMed  Google Scholar 

  101. Vautour L, Melton LJ, Clarke BL et al. (2002) Long-term fracture risk following renal transplantation: a population-based study. J Bone Miner Res 17:S174

    Google Scholar 

  102. Smets YF, van der Pijl JW, de Fijter JW et al. (1998) Low bone mass and high incidence of fractures after successful simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 13:1250–1255

    Article  CAS  PubMed  Google Scholar 

  103. Chiu MY, Sprague SM, Bruce DS et al. (1998) Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol 9:677–683

    CAS  PubMed  Google Scholar 

  104. Shane E, Rivas MDC, Silverberg SJ et al. (1993) Osteoporosis after cardiac transplantation. Am J Med 94:257–264

    CAS  PubMed  Google Scholar 

  105. Shane E, Rivas M, McMahon DJ et al. (1997) Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab 82:1497–1506

    Google Scholar 

  106. Sambrook PN, Kelly PJ, Keogh A et al. (1994) Bone loss after cardiac transplantation: a prospective study. J Heart Lung Transplant 13:116–121

    CAS  PubMed  Google Scholar 

  107. Valimaki MJ, Kinnunen K, Tahtela R et al. (1999) A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin. Osteoporos Int 10:128–136

    Article  CAS  PubMed  Google Scholar 

  108. Thiebaud D, Krieg M, Gillard-Berguer D et al. (1996) Cyclosporine induces high turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 26:549–555

    PubMed  Google Scholar 

  109. Berguer DG, Krieg MA, Thiebaud D et al. (1994) Osteoporosis in heart transplant recipients: a longitudinal study. Transplant Proc 26:2649–2651

    CAS  PubMed  Google Scholar 

  110. Van Cleemput J, Daenen W, Nijs J et al. (1995) Timing and quantification of bone loss in cardiac transplant recipients. Transplant Int 8:196–200

    Google Scholar 

  111. Shane E, Addesso V, Namerow P et al. (2002) Prevention of bone loss after cardiac transplantation with alendronate or calcitriol: efficacy and safety. J Bone Miner Res 17:S135

    Google Scholar 

  112. Henderson NK, Sambrook PN, Kelly PJ et al. (1995) Bone mineral loss and recovery after cardiac transplantation [letter]. Lancet 346:905

    CAS  PubMed  Google Scholar 

  113. Glendenning P, Kent GN, Adler BD et al. (1999) High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry. Clin Endocrinol (Oxf) 50:347–355

    Google Scholar 

  114. Shane E, Rivas M, Staron RB et al. (1996) Fracture after cardiac transplantation: a prospective longitudinal study. J Clin Endocrinol Metab 81:1740–1746

    Google Scholar 

  115. Leidig-Bruckner G, Hosch S, Dodidou P et al. (2001) Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 357:342–347

    CAS  PubMed  Google Scholar 

  116. Sambrook PN, Kelly PJ, Fontana D et al. (1994) Mechanisms of rapid bone loss following cardiac transplantation. Osteoporos Int 4:273–276

    CAS  PubMed  Google Scholar 

  117. Rich GM, Mudge GH, Laffel GL et al. (1992) Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients. J Heart Lung Transplant 11:950–958

    CAS  PubMed  Google Scholar 

  118. Guo C, Johnson A, Locke T et al. (1998) Mechanism of bone loss after cardiac transplantation. Bone 22:267–271

    Article  CAS  PubMed  Google Scholar 

  119. Arnold JC, Hauser R, Ziegler R et al. (1992) Bone disease after liver transplantation. Transplant Proc 24:2709–2710

    CAS  PubMed  Google Scholar 

  120. McDonald JA, Dunstan CR, Dilworth P et al. (1991) Bone loss after liver transplantation. Hepatology 14:613–619

    CAS  PubMed  Google Scholar 

  121. Navasa M, Monegal A, Guanabens N et al. (1994) Bone fractures in liver transplant patients. Br J Rheumatol 33:52–55

    CAS  PubMed  Google Scholar 

  122. Eastell R, Dickson RE, Hodgson SF et al. (1991) Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 14:296–300

    CAS  PubMed  Google Scholar 

  123. Meys E, Fontanges E, Fourcade N et al. (1994) Bone loss after orthotopic liver transplantation. Am J Med 97:445–450

    CAS  PubMed  Google Scholar 

  124. Keogh JB, Tsalamandris C, Sewell RB et al. (1999) Bone loss at the proximal femur and reduced lean mass following liver transplantation: a longitudinal study. Nutrition 15:661–664

    Article  CAS  PubMed  Google Scholar 

  125. Hamburg SM, Piers DA, van den Berg AP et al. 2000 Bone mineral density in the long term after liver transplantation. Osteoporos Int 11:600–606

    Google Scholar 

  126. Ninkovic M, Love S, Tom BD et al. (2002) Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation. J Hepatol 37:93–100

    Article  CAS  PubMed  Google Scholar 

  127. Feller RB, McDonald JA, Sherbon KJ et al. (1999) Evidence of continuing bone recovery at a mean of 7 years after liver transplantation. Liver Transplant Surg 5:407–413

    CAS  Google Scholar 

  128. Giannini S, Nobile M, Ciuffreda M et al. (2000) Long-term persistence of low bone density in orthotopic liver transplantation. Osteoporos Int 11:417–424

    Article  CAS  PubMed  Google Scholar 

  129. Haagsma EB, Thijn CJP, Post JG et al. (1988) Bone disease after liver transplantation. J Hepatol 6:94–100

    CAS  PubMed  Google Scholar 

  130. Ninkovic M, Skingle SJ, Bearcroft PW et al. (2000) Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 12:931–935

    CAS  PubMed  Google Scholar 

  131. Valero M, Loinaz C, Larrodera L et al. (1995) Calcitonin and bisphosphonate treatment in bone loss after liver transplantation. Calcif Tissue Int 57:15–19

    CAS  PubMed  Google Scholar 

  132. Abdelhadi M, Eriksson SA, Ljusk Eriksson S et al. (1995) Bone mineral status in end-stage liver disease and the effect of liver transplantation. Scand J Gastroenterol 30:1210–1215

    CAS  PubMed  Google Scholar 

  133. Watson RG, Coulton L, Kanis JA et al. (1990) Circulating osteocalcin in primary biliary cirrhosis following liver transplantation and during treatment with ciclosporin. J Hepatol 11:354–358

    CAS  PubMed  Google Scholar 

  134. Vedi J, Greer S, Skingle S et al. (1999) Mechanism of bone loss after liver transplantation: a histomorphometric analysis. J Bone Miner Res 14:281–287

    CAS  PubMed  Google Scholar 

  135. Hawkins FG, Leon M, Lopez MB et al. (1994) Bone loss and turnover in patients with liver transplantation. Hepato-Gastroenterol 41:158–161

    Google Scholar 

  136. Compston J, Greer S, Skingle S et al. (1996) Early increase in plasma parathyroid hormone level following liver transplantation. J Hepatol 25:715–718

    Article  CAS  PubMed  Google Scholar 

  137. Spira A, Gutierrez C, Chaparro C et al. (2000) Osteoporosis and lung transplantation: a prospective study. Chest 117:476–481

    Article  CAS  PubMed  Google Scholar 

  138. Shane E, Papadopoulos A, Staron RB et al. (1999) Bone loss and fracture after lung transplantation. Transplantation 68:220–227

    CAS  PubMed  Google Scholar 

  139. Aringer M, Kiener H, Koeller M et al. (1998) High turnover bone disease following lung transplantation. Bone 23:485–488

    Article  CAS  PubMed  Google Scholar 

  140. Haworth CS, Webb AK, Egan JJ et al. (2000) Bone histomorphometry in adult patients with cystic fibrosis. Chest 118:434–439

    Article  CAS  PubMed  Google Scholar 

  141. Stern JM, III CHC, Bruemmer B et al. (1996) Bone density loss during treatment of chronic GVHD. Bone Marrow Transplant 17:395–400

    CAS  PubMed  Google Scholar 

  142. Ebeling P, Thomas D, Erbas B et al. (1999) Mechanism of bone loss following allogeneic and autologous hematopoeitic stem cell transplantation. J Bone Miner Res 14:342–350

    CAS  PubMed  Google Scholar 

  143. Kang MI, Lee WY, Oh KW et al. (2000) The short-term changes of bone mineral metabolism following bone marrow transplantation. Bone 26:275–279

    Article  CAS  PubMed  Google Scholar 

  144. Valimaki M, Kinnunen K, Volin L et al. (1999) A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant 23:355–361

    Article  CAS  PubMed  Google Scholar 

  145. Lee WY, Cho SW, Oh ES et al. (2002) The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab 87:329–335

    Google Scholar 

  146. Carlson K, Simonsson B, Ljunghall S (1994) Acute effects of high dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism. Calcif Tissue Int 55:408–411

    CAS  PubMed  Google Scholar 

  147. Tauchmanova L, Serio B, Del Puente A et al. (2002) Long-lasting bone damage detected by dual-energy X-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation. J Clin Endocrinol Metab 87:5058–5065

    Google Scholar 

  148. Liberman UA, Weiss SR, Broll J et al. (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437–1443

    CAS  PubMed  Google Scholar 

  149. Saag K, Emkey R, Schnitzer T et al. (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 339:292–299

    Article  CAS  PubMed  Google Scholar 

  150. Sambrook P (1999) Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation. Calcif Tissue Int 65:341–343

    Article  CAS  PubMed  Google Scholar 

  151. Lemire JM (1992) Immunomodulatory role of 1,25 Dihydroxyvitamin D3. J Cell Biochem 49:26–31

    CAS  PubMed  Google Scholar 

  152. Lemire JM, Archer DC, Reddy GS (1994) Dihydroxy-24-oxo-16-ene-vitamin D3, a renal metabolite of the vitamin D analog 1,25-dihydroxy-16ene-vitamin D3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo. Endocrinology 135:2818–2821

    CAS  PubMed  Google Scholar 

  153. Meys E, Terreaux-Duvert F, Beaume-Six T et al. (1993) Effects of calcium, calcidiol, and monofluorophosphate on lumbar bone mass and parathyroid function in patients after cardiac transplantation. Osteoporos Int 3:329–332

    Google Scholar 

  154. Garcia-Delgado I, Prieto S, Fragnas LG et al. (1997) Calcitonin, editronate and calcidiol treatment in bone loss after cardiac transplantation. Calcif Tissue Int 60:155–159

    Article  CAS  PubMed  Google Scholar 

  155. Sambrook P, Henderson NK, Keogh A et al. (2000) Effect of calcitriol on bone loss after cardiac or lung transplantation. J Bone Miner Res 15:1818–1824

    CAS  PubMed  Google Scholar 

  156. Neuhaus R, Kubo A, Lohmann R et al. (1999) Calcitriol in prevention and therapy of osteoporosis after liver transplantation. Transplant Proc 31:472–473

    CAS  PubMed  Google Scholar 

  157. Henderson K, Eisman J, Keogh A et al. (2001) Protective effect of short-tem calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation. J Bone Miner Res 16:565–571

    CAS  PubMed  Google Scholar 

  158. Ugur A, Guvener N, Isiklar I et al. (2000) Efficiency of preventive treatment for osteoporosis after renal transplantation. Transplant Proc 32:556–557

    Article  CAS  PubMed  Google Scholar 

  159. Stempfle HU, Werner C, Siebert U et al. (2002) The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation 73:547–552

    Google Scholar 

  160. Neuhaus R, Lohmann R, Platz KP et al. (1995) Treatment of osteoporosis after liver transplantation. Transplant Proc 27:1226–1227

    CAS  PubMed  Google Scholar 

  161. Van Cleemput J, Daenen W, Geusens P et al. (1996) Prevention of bone loss in cardiac transplant recipients. A comparison of biphosphonates and vitamin D. Transplantation 61:1495–1499

    PubMed  Google Scholar 

  162. Cueto-Manzano AM, Konel S, Freemont AJ et al. (2000) Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation. Am J Kidney Dis 35:227–236

    CAS  PubMed  Google Scholar 

  163. Stempfle HU, Werner C, Echtler S et al. (1999) Prevention of osteoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation 68:523–530

    CAS  PubMed  Google Scholar 

  164. Aris RM, Lester GE, Renner JB et al. (2000) Efficacy of pamidronate for osteoporosis in cystic fibrosis patients following lung transplantation. Am J Respir Crit Care Med 162:941

    Google Scholar 

  165. Bianda T, Linka A, Junga G et al. (2000) Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate. Calcif Tissue Int 67:116–121

    Article  CAS  PubMed  Google Scholar 

  166. Fan S, Almond MK, Ball E et al. (2000) Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int 57:684–690

    Article  CAS  PubMed  Google Scholar 

  167. Kovac D, Lindic J, Kandus A et al. (2001) Prevention of bone loss in kidney graft recipients. Transplant Proc 33:1144–1145

    Article  CAS  PubMed  Google Scholar 

  168. Shane E, Rodino MA, McMahon DJ et al. (1998) Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study. J Heart Lung Transplant 17:1089–1096

    CAS  PubMed  Google Scholar 

  169. Hommann M, Abendroth K, Lehmann G et al. (2002) Effect of transplantation on bone: osteoporosis after liver and multivisceral transplantation. Transplant Proc 34:2296–2298

    Article  CAS  PubMed  Google Scholar 

  170. Arlen DJ, Lambert K, Ioannidis G et al. (2001) Treatment of established bone loss after renal transplantation with etidronate. Transplantation 71:669–673

    CAS  PubMed  Google Scholar 

  171. Krieg M, Seydoux C, Sandini L et al. (2001) Intravenous pamidronate as a treatment for osteoporosis after heart transplantation: a prospective study. Osteoporos Int 12:112–116

    Article  CAS  PubMed  Google Scholar 

  172. Reeves H, Francis R, Manas D et al. (1998) Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation. Liver Transplant Surg 4:404–409

    CAS  Google Scholar 

  173. Riemens SC, Oostdijk A, Doormaal Jv et al. (1996) Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alpha calcidiol. Osteoporos Int 6:213–218

    CAS  PubMed  Google Scholar 

  174. Giannini S, Dangel A, Carraro G et al. (2001) Alendronate prevents further bone loss in renal transplant recipients. J Bone Miner Res 16:2111–2117

    CAS  PubMed  Google Scholar 

  175. Sambrook PN, Birmingham J, Kelly P et al. (1993) Prevention of corticosteroid osteoporosis; a comparison of calcium, calcitriol and calcitonin. N Engl J Med 328:1747–1752

    Article  CAS  PubMed  Google Scholar 

  176. Mazzuoli G, Passeri M, Gennari C et al. (1986) Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcif Tissue Int 38:3–8

    CAS  PubMed  Google Scholar 

  177. Cremer J, Struber M, Wagenbreth I et al. (1999) Progression of steroid-associated osteoporosis after heart transplantation. Ann Thorac Surg 67:130–133

    Article  CAS  PubMed  Google Scholar 

  178. Hay JE, Malinchoc M, Dickson ER (2001) A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 34:292–298

    Article  CAS  PubMed  Google Scholar 

  179. Isoniemi H, Appelberg J, Nilsson CG et al. (2001) Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. A 2-year follow-up study. J Hepatol 34:299–305

    Article  CAS  PubMed  Google Scholar 

  180. Castelo-Branco C, Rovira M, Pons F et al. (1996) The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation. Maturitas 23:307–312

    Article  CAS  PubMed  Google Scholar 

  181. Rossouw JE, Anderson GL, Prentice RL et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321–333

    PubMed  Google Scholar 

  182. Fahrleitner A, Prenner G, Tscheliessnigg KH et al. (2002) Testosterone supplementation has additional benefits on bone metabolism in cardiac transplant recipients receiving intravenous bisphosphonate treatment: a prospective study. J Bone Miner Res 17:S388

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Physicians & Surgeons of Columbia University, 630 West 168th Street, New York, NY, 10032, USA

    Adi Cohen & Elizabeth Shane

Authors
  1. Adi Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth Shane
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth Shane.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cohen, A., Shane, E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int 14, 617–630 (2003). https://doi.org/10.1007/s00198-003-1426-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-003-1426-z

Keywords

Search

Navigation